skip navigation


Register for Latest Research

Stay Informed
Register with NCJRS to receive NCJRS's biweekly e-newsletter JUSTINFO and additional periodic emails from NCJRS and the NCJRS federal sponsors that highlight the latest research published or sponsored by the Office of Justice Programs.

NCJRS Abstract

The document referenced below is part of the NCJRS Virtual Library collection. To conduct further searches of the collection, visit the Virtual Library. See the Obtain Documents page for direction on how to access resources online, via mail, through interlibrary loans, or in a local library.


NCJ Number: 83442 Find in a Library
Title: Testimony of Rudolph Giuliani on March 29, 1982 Concerning Coordination Between the Drug Enforcement Agency and the Federal Bureau of Investigation
Author(s): R Guiliani
Date Published: 1982
Page Count: 13
Sponsoring Agency: National Institute of Justice/
Rockville, MD 20849
Sale Source: National Institute of Justice/
NCJRS paper reproduction
Box 6000, Dept F
Rockville, MD 20849
United States of America
Document: PDF
Language: English
Country: United States of America
Annotation: The nature and benefits of a restructuring of the relationship between the Drug Enforcement Agency (DEA) and the Federal Bureau of Investigation (FBI) are described.
Abstract: In the realignment of responsibilities, DEA will continue as a law enforcement agency headed by an administrator; however, the administrator of DEA will report to the Department of Justice through the Director of the FBI. The Director of the FBI will ensure that maximum available FBI resources are used effectively to supplement DEA's existing resources and expertise. Further, the FBI has been assigned jurisdiction over the violations of the Federal criminal drug laws, concurrent with the jurisdiction of DEA. The administrator of DEA, subject to the general supervision of the Director of the FBI, is responsible for developing strategies for joint DEA/FBI drug enforcement efforts and should ensure that DEA is organized for effective drug enforcement. The principal benefits for Federal drug law enforcement in this realignment are that (1) additional personnel will be available for drug enforcement; (2) more sophisticated investigative tools will be available; (3) the proposed structure will enhance asset seizure efforts; and (4) the FBI's network of informants and criminal intelligence can be used in drug cases. DEA and FBI training officials have been cooperating to develop cross-training programs that will give all agents knowledge of their tasks under the new structure. At the field level, the Attorney General has begun an innovative program to ensure that the drug problem is addressed in a manner that will address local needs.
Index Term(s): Drug Enforcement Administration (DEA); Drug law enforcement; Federal Bureau of Investigation (FBI); Federal law enforcement agencies; Interagency cooperation
To cite this abstract, use the following link:

*A link to the full-text document is provided whenever possible. For documents not available online, a link to the publisher's website is provided. Tell us how you use the NCJRS Library and Abstracts Database - send us your feedback.